Endocrine toxicities of immune checkpoint inhibitors: What differs from other immune-related adverse events

被引：0
|
作者：
Lecoq, A. L. [1 ]
Becquemont, L. [1 ]
Chanson, P. [2 ]
机构：
[1] Hop Bicetre, AP HP, Ctr Rech Clin Paris Saclay, Le Kremlin Bicetre, France
[2] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2022年 / 36卷
关键词：
immune check point inhibitors; immune-related adverse events; endocrinopathies; hormonal deficiencies;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS-078
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [41] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sabina Sandigursky
    Adam Mor
    Current Rheumatology Reports, 2018, 20
  • [42] Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors
    Li Zhong
    Qing Wu
    Fuchun Chen
    Junjin Liu
    Xianhe Xie
    Cancer Immunology, Immunotherapy, 2021, 70 : 2559 - 2576
  • [43] Immune-related adverse events (IrAEs) in patients receiving immune checkpoint inhibitors
    Ferrarini, Alessia
    Benfaremo, Devis
    Rossetti, Giulia
    Morgese, Francesca
    Pomponio, Giovanni
    Berardi, Rossana
    Gabrielli, Armando
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [44] Treatment options for immune-related adverse events associated with immune checkpoint inhibitors
    Chen, Yu Hua
    Kovacs, Tamas
    Ferdinandy, Peter
    Varga, Zoltan V.
    BRITISH JOURNAL OF PHARMACOLOGY, 2024,
  • [45] Vitamin D, autoimmunity and immune-related adverse events of immune checkpoint inhibitors
    Lillian Sun
    Joshua Arbesman
    Melissa Piliang
    Archives of Dermatological Research, 2021, 313 : 1 - 10
  • [46] Immune-related adverse events associated with immune checkpoint inhibitors in patients with cancer
    Samanci, Nilay Sengul
    Cikman, Duygu Ilke
    Oruc, Kerem
    Bedir, Sahin
    Celik, Emir
    Degerli, Ezgi
    Derin, Sumeyra
    Demirelli, Fuat Hulusi
    Ozguroglu, Mustafa
    TUMORI JOURNAL, 2021, 107 (04): : 304 - 310
  • [47] Assessment of hospitalization rates for immune-related adverse events with immune checkpoint inhibitors
    Nice, Laura
    Bycroft, Ryan
    Wu, Xiaoyong
    Rai, Shesh N.
    Figg, Lindsay
    Bhandari, Shruti
    Burd, Megan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1736 - 1742
  • [48] Checkpoint Inhibitors Common immune-related adverse events and their management
    Gordon, RuthAnn
    Kasler, Mary Kate
    Stasi, Kristen
    Shames, Yelena
    Errante, Mimma
    Ciccolini, Kathryn
    Lucas, Anna Skripnik
    Raasch, Pam
    Fischer-Cartlidge, Erica
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (02) : 45 - 52
  • [49] Immune-related cutaneous adverse events due to checkpoint inhibitors
    Wang, Evelyn
    Kraehenbuehl, Lukas
    Ketosugbo, Kwami
    Kern, Jeffrey A.
    Lacouture, Mario E.
    Leung, Donald Y. M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (06) : 613 - 622
  • [50] Dermatologic immune-related adverse events to checkpoint inhibitors in cancer
    Shah, Neil J.
    Lacouture, Mario E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : 407 - 409
12345